Sex: M
Vaccine: COVID19
Symptoms: Myocarditis
Clinical narrative: heart inflammation; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown), in arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDITIS (death, medically significant), outcome "fatal", described as "heart inflammation". The patient date of death was unknown. Reported cause of death: "heart inflammation". It was not reported if an autopsy was performed.  Clinical notes: Is a Registered Nurse with a doctorate from (name) University. She is a faculty member States in 1951 when she first learned to give injections she was taught to draw back to make sure she didn't get into a blood vessel. Even when she went in to get the COVID-19 Vaccine, she found a nurse in the practice who draws back. as not seen one person on TV who draws back and there have been people getting those injections left and right. Millions of people are getting them. Very few nurses are taught to draw back. Found out by the Supervisor of the Department of Health that the syringe company tells them not to draw back. Caller asks what right does the syringe company have to tell them this? States people draw back when they fill the syringe. States you don't know if you are in a blood vessel if you don't draw back. Asks this agent if she draws back when she gives an intramuscular injection. Article was reported about a research study by the Archives written for that group of people. Called to see if she could talk to that article writer. No where did she see on the manifestation of myocarditis. Didn't see any discussion or reaction to how it was given. She looked it up on the internet and COVID-19 Vaccine may not be given intravenously because you'll get myocarditis. Looking at the numbers of death, there are two little boys. The article was titled and nobody is finding if the COVID-19 Vaccines were given in a blood vessel or not. Drawing back, or aspirating, is not being taught. Something stopped it.  There are still nurses being taught that, but doctors are rarely taught. Doctor complaining about people aren't aspirating anymore. States she is a researcher and doesn't let things die. She is going to find out about this. (name), the person who wrote the article, is going to call her. States the article was poorly written and didn't reference who wrote the research, just references a study. All research studies about the disease and how did the poor guy get it. Nobody thinks about the injection going into a blood vessel.  Already got on the computer and it says not to give COVID-19 Vaccine that way. Caller asks doesn't anyone realize that no one is drawing back when giving injections. People are giving the COVID-19 Vaccines intravenously and that is serious. The labs don't want it given that way because it causes myocarditis and inflammation of the heart.  Thinks Pfizer should find out and find these people who died to determine if there injections were given by people who didn't draw back. Wants this to be written. States maybe she will write an article herself to let the public know that people should aspirate. Doesn't know what to do about it.  In the meantime, a lot of people figure that it happens so seldom, it's not worth it. As far as caller is sure, 57 people could have lived. Caller has no patient identifiers to provide and declines report. She is a nurse educator.  States people need to look at what route the COVID-19 Vaccine should be given. Pfizer needs to make a change and put in big print that when giving the COVID-19 Vaccine injections, it needs to be drawn back. Wants Pfizer to emphasize drawing back and put it in large print on the box. Says she thinks COVID-19 Vaccines come in little dosage bottles. She understands this problem is with Medina and Pfizer COVID-19 Vaccines. Attempted to clarify other manufacturer, but caller provides it as Medina. States this could be true of any vaccine because vaccines create an inflammation in your body to create the antibodies Email: unknown. Reporter Type: Confirmed she has a doctorate in nursing, she is not a physician. She is a Registered Nurse.  Wants Pfizer to follow up with her immediately.  States the article isn't scholarly. Keeps talking about a study then reported by Pathology and Laboratory Medicine. Knows Pfizer knows COVID-19 Vaccines causes myocarditis but doesn't know that the myocarditis is because it's being giving intravenously to some people. Confirmed caller has no patient information or NDC/LOT/EXP for any COVID-19 Vaccines. In order to correct this, the material Pfizer reads, writes on the box should say to draw back and aspirate to ensure the injection is not being given into a vein.  Regarding her previous statement about how the syringe company advised to stop aspirating, confirmed she does not have a specific manufacturer of a syringe or an NDC/LOT/EXP.  She needed to get a Flu shot and the supervisor or public health didn't draw back. When caller asked why, the administrator said they are advised not to draw back during injections anymore per the syringe company. Syringe company wrote do not draw back. States this was when syringes moved from glass to plastic. Pfizer is welcome to call her. Asked what time does the labs close. She is going to try and call (name). Wants to blame it on the Pharmaceuticals because they made the myocarditis a side effect but it could be prevented if nurses and doctors would bring back aspirating during injections.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on limited information in the case , a possible causal association between  all the reported  event Myocarditis and the suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate,Linked Report(s) : US-PFIZER INC-202200649706 similar report from same reporter; Reported Cause(s) of Death: heart inflammation